Eli Lilly also completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc., adding a therapy for inflammatory bowel disease to its portfolio. In an effort to make its obesity treatment drug ...

Eli Lilly also completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc., adding a therapy for inflammatory bowel disease to its portfolio. In an effort to make its obesity treatment drug, ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a biopharmaceutical company developing oral integrin ...

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic is a biopharmaceutical company developing oral ...

The Japanese June Economy Watchers Current Index arrived at 47.0, stronger than expectations of 46.1. Pre-Market U.S. Stock Movers Morphic Holding (MORF) soared about +77% in pre-market trading ...

The company completed the acquisition of Morphic Holding (NASDAQ:MORF), Inc., adding a therapy for inflammatory bowel disease to its portfolio. BMO Capital and Morgan Stanley have maintained their ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a global pharmaceutical firm, announced today the appointment of Lucas Montarce as the new Executive Vice President and Chief Financial Officer (CFO).

Lastly, Raymond James initiates coverage on chip designer Arm Holding (ARM) with an Outperform rating and a price target of $160 per share. For more expert insight and the latest market action ...